Trial intelligence / Profile preview

Hib immunogenicity study in infants in Kathmandu

ISRCTN58764892Phase 4Completed

Sponsor
University of Oxford
Start
Aug 2008
Modality
Vaccines & Immunotherapeutics
01

Overview

Phase 4, open-label trial of haemophilus influenzae type b vaccine in Haemophilus influenzae type b disease (Hib) (2 arms), sponsored by University of Oxford. Started Aug 2008; status: completed.

02

Drugs

haemophilus influenzae type b vaccine
03

Conditions

Haemophilus influenzae type b disease (Hib)

Beyond the preview

Go deeper on ISRCTN58764892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN58764892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call